Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-011330
Filing Date
2023-04-12
Accepted
2023-04-11 20:52:54
Documents
12
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 6-K form6-kx2023q21.htm 6-K 12764
2 EX-99.1 organigramholdingsinc-2mda.htm EX-99.1 788465
3 EX-99.2 organigramholdingsinc-1fsx.htm EX-99.2 588015
4 EX-99.3 a993ceocertification.htm EX-99.3 15188
5 EX-99.4 a994cfocertification.htm EX-99.4 15176
6 EX-99.5 organigramholdingsinc-3prx.htm EX-99.5 198694
7 a2023_q1xcoversxbacka.jpg GRAPHIC 163902
8 a2023_q1xcoversxbackb.jpg GRAPHIC 163902
9 a2023_q2xcoversxfinancialsa.jpg GRAPHIC 1996528
10 a2023_q2xcoversxmdaa.jpg GRAPHIC 1970803
11 assets_inventorya.jpg GRAPHIC 1045505
12 blueleafsa.gif GRAPHIC 559128
  Complete submission text file 0001628280-23-011330.txt   9538672
Mailing Address 35A ENGLISH DR. MONCTON A3 E1E 3X3
Business Address 35A ENGLISH DR. MONCTON A3 E1E 3X3 506-384-1571
ORGANIGRAM HOLDINGS INC. (Filer) CIK: 0001620737 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0831
Type: 6-K | Act: 34 | File No.: 001-38885 | Film No.: 23814471
SIC: 2834 Pharmaceutical Preparations